Work

253 Screening for PIK3CA, RAS, and RAF mutations in trials with PI3K/AKT/mTOR signaling pathway inhibitors

Year: 2010

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(10)71959-5

Authors: F. Janku, A.M. Tsimberidou, I. Garrido-Laguna, D.S. Hong, A.M. Naing, G.S. Falchook, S. Fu, R. Luthra, X. Wang, R. Kurzrock

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1984512458

Cites:

Cited by:

Related to: 10